HKD 0.4
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 95.4 Million HKD | 37.04% |
2022 | 69.61 Million HKD | -8.17% |
2021 | 75.81 Million HKD | -26.91% |
2020 | 103.72 Million HKD | 98.84% |
2019 | 52.16 Million HKD | 386.77% |
2018 | 10.71 Million HKD | -84.89% |
2017 | 70.93 Million HKD | -29.57% |
2016 | 100.71 Million HKD | 55.29% |
2015 | 64.85 Million HKD | 1.75% |
2014 | 63.73 Million HKD | 41.21% |
2013 | 45.13 Million HKD | 18.49% |
2012 | 38.09 Million HKD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 Q4 | 108.22 Million HKD | 0.0% |
2023 Q2 | 100.96 Million HKD | 0.0% |
2022 Q2 | 46.12 Million HKD | 0.0% |
2022 FY | 69.61 Million HKD | -8.17% |
2022 Q4 | 20.61 Million HKD | 0.0% |
2021 FY | 75.81 Million HKD | -26.91% |
2021 Q2 | 55.67 Million HKD | 0.0% |
2021 Q4 | 24.48 Million HKD | 0.0% |
2020 Q4 | 19 Million HKD | 0.0% |
2020 FY | 103.72 Million HKD | 98.84% |
2020 Q2 | 48.93 Million HKD | 0.0% |
2019 Q4 | 1.49 Million HKD | 0.0% |
2019 FY | 52.16 Million HKD | 386.77% |
2019 Q2 | 48.77 Million HKD | 0.0% |
2018 Q3 | 22.29 Million HKD | 200.77% |
2018 Q1 | 17.73 Million HKD | -11.53% |
2018 FY | 10.71 Million HKD | -84.89% |
2018 Q4 | 29.54 Million HKD | 32.49% |
2018 Q2 | -22.12 Million HKD | -224.78% |
2017 Q4 | 20.04 Million HKD | 13.04% |
2017 Q1 | 12.74 Million HKD | 165.88% |
2017 Q2 | 17.61 Million HKD | 38.18% |
2017 Q3 | 17.73 Million HKD | 0.66% |
2017 FY | 70.93 Million HKD | -29.57% |
2016 Q3 | 12.74 Million HKD | -6.67% |
2016 FY | 100.71 Million HKD | 55.29% |
2016 Q4 | 4.79 Million HKD | -62.39% |
2016 Q2 | 13.66 Million HKD | -14.47% |
2016 Q1 | 15.97 Million HKD | -29.28% |
2015 Q4 | 22.58 Million HKD | 41.41% |
2015 FY | 64.85 Million HKD | 1.75% |
2015 Q3 | 15.97 Million HKD | 59.57% |
2015 Q1 | 14.78 Million HKD | -31.3% |
2015 Q2 | 10 Million HKD | -32.28% |
2014 Q3 | 14.78 Million HKD | -20.73% |
2014 FY | 63.73 Million HKD | 41.21% |
2014 Q1 | 9.32 Million HKD | 0.0% |
2014 Q4 | 21.51 Million HKD | 45.55% |
2014 Q2 | 18.64 Million HKD | 100.0% |
2013 FY | 45.13 Million HKD | 18.49% |
2012 FY | 38.09 Million HKD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aidigong Maternal & Child Health Limited | -106.11 Million HKD | 189.904% |
Human Health Holdings Limited | 87.71 Million HKD | -8.758% |
EuroEyes International Eye Clinic Limited | 193.51 Million HKD | 50.701% |
Kato (Hong Kong) Holdings Limited | 116.95 Million HKD | 18.429% |
Bamboos Health Care Holdings Limited | 40.72 Million HKD | -134.271% |
Beijing Health (Holdings) Limited | -65.9 Million HKD | 244.756% |
C-MER Eye Care Holdings Limited | 116.43 Million HKD | 18.062% |
Town Health International Medical Group Limited | 102.44 Million HKD | 6.88% |
Medicskin Holdings Limited | - HKD | -Infinity% |
Hang Chi Holdings Limited | 24.54 Million HKD | -288.611% |